Search Results

You are looking at 1 - 10 of 122 items for :

  • pharmacokinetics x
  • Pharmacy, other x
Clear All
Open access

Ting-Ting Li, Jian-Zhong Xie, Ling Wang, Yang-Yang Gao and Xue-Hua Jiang

, C. A. Martinusso, C. M. Takiya, A. J. Silva, J. F. Ornellas, P. R. Elias, M. Leite, Jr. and L. R. Cardoso, Fructose-1,6-diphosphate as a protective agent for experimental ischemic acute renal failure, Kidney Int. 69 (2006) 68-72; DOI: 10.1038/sj.ki.5000013. 10. K. Xu and J. L. Stringer, Pharmacokinetics of fructose-1, 6-diphosphate after intraperitoneal and oral administration to adult rats, Pharmacol. Res. 57 (2008) 234-238; DOI 10.1016/j.phrs.2008.01.008. 11. S. Drabant, I. Klebovich, B. Gachalyi, G. Renczes and C. Farsang, Role

Open access

Wusan Wang, Hui Ji, Tingting Li, Yuanwei Jia and Haitang Xie

-term memory, Proc. Natl. Acad. Sci. USA 91 (1994) 2041–2045. 4. C. Mondadori, H. J. Möbius and J. Borkowski, The GABAB receptor antagonist CGP 36,742 and the nootropic oxiracetam facilitate the formation of long-term memory, Behav. Brain Res . 77 (1996) 223–225. 5. W. H. Brooks, W. C. Guida and K. G. Daniel, The significance of chirality in drug design and development, Curr. Top. Med. Chem . 11 (2011) 760–770; DOI: 10.2174/156802611795165098. 6. A. J. Hutt, Chirality and pharmacokinetics: an area of neglected dimensionality, Drug Metabol. Drug

Open access

Fugen Gu, Jia Ning, Huimin Fan, Chunzhi Wu and Yi Wang

-005-4594-z 3. M. Schachter, Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update, Fundam. Clin. Pharmacol . 19 (2005) 117–125; https://doi.org/10.1111/j.1472-8206.2004.00299.x 4. A. Fattahi, J. Karimi-Sabet, A. Keshavarz, A. Golzary, M. Rafiee-Tehrani and F. A. Dorkoosh, Preparation and characterization of simvastatin nanoparticles using rapid expansion of supercritical solution (RESS) with trifluoromethane, J. Supercrit. Fluids 107 (2016) 469–478; https://doi.org/10.1016/j.supflu.2015.05.013 5. J. K. Patel and V. B

Open access

Aleksandra Kapedanovska Nestorovska, Krume Jakjovski, Zorica Naumovska, Zoran Sterjev, Nadica Matevska Geskovska, Kristina Mladenovska, Ljubica Suturkova and Aleksandar Dimovski

REFERENCES 1. K. D. Rainsford, Fifty years since the discovery of ibuprofen, Inflammopharmacol. 19 (2011) 293–297; https://doi.org/10.1007/s10787-011-0103-7 2. M. De Martino, A. Chiarugi, A. Boner, G. Montini and L. de’ Angelis, Working towards an appropriate use of ibuprofen in children: An evidence-based appraisal, Drugs 77 (2017) 1295–1311; https://doi.org/10.1007/s40265-017-0751-z . 3. H. Hao, G. Wang and Sun, Enantioselective pharmacokinetics of ibuprofen and involved mechanisms, Drug Metab. Rev . 37 (2005) 215–234; https

Open access

Zhaoxiang Zhou, Meng Wang, Zengjun Guo and Xiaoying Zhang

flavonoid, kaempferol on human health and cancer chemoprevention, Food Chem. 138 (2013) 2099-2107; DOI: 10.1016/j.foodchem.2012.11.139. 4. A. Barve, C. Chen, V. Hebbar, J. Desiderio, C. L. Saw and A. Kong, Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats, Biopharm. Drug Dispos. 30 (2009) 356-365; DOI: 10.1002/bdd.677. 5. M. K. Piskula and J. Terao, Quercetin’s solubility affects its accumulation in rat plasma after oral administration, J. Agric. Food Chem. 10 (1998) 4313-4317; DOI: 10.1021/jf980117

Open access

Fugen Gu, Weina Ma, Gendalai Meng, Chunzhi Wu and Yi Wang

References 1. T. Cabaleiro, D. Ochoa, R. López-Rodríguez, M. Román, J. Novalbos, C. Ayuso and F. Abad-Santos, Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers, Hum. Psychopharmacol. 29 (2014) 459-469; DOI: 10.1002/hup.2420. 2. J. L. Sun, Q. X. Chen, S. Tian, F. R. Meng, Y. Lv and G. H. Du, Absorption of risperidone polymorphs administrated orally in rats, Chin. Pharm. J. 46 (2011) 1919-1922. 3. T. K. Vyas, A. Shahiwala, S. Marathe and A. Misra

Open access

Gongwen Liang, Na Li, Liping Ma, Zhonglian Qian, Yuwen Sun, Luwen Shi and Libo Zhao

. DeArmond and S. B. Prusiner, Pharmacokinetics of quinacrine efflux from mouse brain via the P-glycoprotein efflux transporter, PLoS One 7 (2012) e39112; DOI: 10.1371/journal.pone.0039112. 4. D. Pal, D. Kwatra, M. Minocha, D. K. Paturi, B. Budda and A. K. Mitra, Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals, Life Sci. 88 (2011) 959–971; DOI: 10.1016/j.lfs.2010.09.012. 5. A. Antinori, G. Arendt, J. T. Becker, B. J. Brew, D. A. Byrd, M. Cherner, D. B. Clifford, P. Cinque, L. G. Epstein, K

Open access

Shan Xiong, Jinglai Li, Yanling Mu and Zhenqing Zhang

.04.013 11. W. Wang, J. Xu, L. Li, P. Wang, X. Ji, H. Ai, L. Zhang and L. Li, Neuroprotective effect of morroniside on focal cerebral ischemia in rats, Brain Res. Bull . 83 (2010) 196–201; https://doi.org/10.1016/j.brainresbull.2010.07.003 12. P. Mehta, R. Shah, S. Lohidasan and K. R. Mahadik, Pharmacokinetic profile of phytoconstituent(s) isolated from medicinal plants - A comprehensive review, J. Tradit. Complement. Med . 5 (2015) 207–227; https://doi:10.1016/j.jtcme.2014.11.041 13. S. Xiong, J. L. Li, X. Q. Zhu, X. Y. Wang, G. Y. Lv and Z. Q. Zhang

Open access

Fengling Wang, Jin Chen, Wenting Dai, Zhengmin He, Dandan Zhai and Weidong Chen

anticancer properties of curcumin, Exp. Theor. Med. 10 (2015) 1615–1623. 6. M. Kanai, Y. Otsuka, K. Otsuka, M. Sato, T. Nishimura, Y. Mori, M. Kawaguchi, E. Hatano, Y. Kodama, S. Matsumoto, Y. Murakami, A. Imaizumi, T. Chiba, J. Nishihira and H. Shibata, A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients, Cancer Chemother. Pharmacol. 71 (2013) 1521–1530; DOI: 10.1007/s00280-013-2151-8. 7. H. A. Hazzah, R. M. Farid, M. M. Nasra, M. A. El-Massik and O. Y. Abdallah, Lyophilized

Open access

Bruno Louis and Vijay K. Agrawal

structure-pharmacokinetic parameters relationships (QSPKR) analysis of antimicrobial agents in humans using simulated annealing k-nearest-neighbor and partial least-square analysis methods, J. Pharm. Sci. 93 (2004) 2535-2544; DOI: 10.1002/jps.20117. 4. J. V. Turner, D. J. Maddalena, D. J. Cutler and S. Agatonovic-Kustrin, Multiple pharmacokinetic parameter prediction for a series of cephalosporins, J. Pharm. Sci. 92 (2003) 552-559; DOI: 10.1002/jps.10314. 5. R. S. Obach, F. Lombardo and N. J. Waters, Trend analysis of a database of